Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 3/20 | 0.61 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | GPR3 | P46089 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.52 |
| ▸ | DHODH | Q02127 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30537037 | 1.00 | NUDT1 (0.61) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| Iodide SCHEMBL31032485 | 0.98 | NUDT1 (0.59) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL23607638 | 0.92 | KDM4E (0.55) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL19009488 | 0.90 | MEN1 (0.67) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL23606988 | 0.87 | MEN1 (0.63) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL712287 | 0.86 | NUDT1 (0.47) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL15561040 | 0.86 | MEN1 (0.69) | NUDT1ADORA2AMEN1KMT2AMAPT | |
| SCHEMBL28202635 | 0.86 | KDM4E (0.69) | NUDT1ADORA2AGAAKDM4EPKM | |
| SCHEMBL12578343 | 0.86 | CYP1B1 (0.51) | NUDT1ADORA2AMEN1KMT2AGAA | |
| SCHEMBL28232225 | 0.86 | ADORA2A (0.67) | NUDT1ADORA2AKMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112505023-B | Method for improving electrochemiluminescence signal in bioassay | 周明 | 2024-08-23 | — | — | CN | claimed |
| EP-3426398-B1 | BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION | ROCHE DIAGNOSTICS GMBH (DE) | 2024-01-24 | — | — | EP | claimed |
| CN-108698047-B | Branched amines in electrochemiluminescence detection | 豪夫迈·罗氏有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-108314649-B | Synthetic method of 6-phenylphenanthridine compound | 温州大学 | 2021-03-19 | — | — | CN | claimed |
| US-20050187278-A1 | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors | PHARMACIA CORPORATION (US) | 2005-08-25 | — | — | US | claimed |
| WO-2005020926-A2 | TREATMENT OR PREVENTION OF VASCULAR DISORDERS WITH COX-2 INHIBITORS IN COMBINATION WITH CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE INHIBITORS | PHARMACIA CORPORATION (US) | 2005-03-10 | — | — | WO | claimed |
| US-12570676-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12372474-B2 | Branched-chain amines in electrochemiluminescence detection | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4174078-B1 | ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | BEIJING SUMMER SPROUT TECH CO LTD (CN) | 2024-12-04 | — | — | EP | disclosed |
| US-20240327703-A1 | IRIDIUM COMPLEX, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY DEVICE, IMAGING DEVICE, ELECTRONIC DEVICE, LIGHTING DEVICE, AND MOVING BODY | CANON KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-112505023-B | Method for improving electrochemiluminescence signal in bioassay | 周明 | 2024-08-23 | — | — | CN | disclosed |
| CN-114641554-B | Method for improving electrochemiluminescence signal in bioassay | 苏州安赛诊断技术有限公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118234709-A | Hydrophilic azadibenzocyclooctyne derivatives and metal-free click reactions with these hydrophilic azadibenzocyclooctyne derivatives | 豪夫迈·罗氏有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-0355575-B1 | Method of preventing polymer scale formation | SHINETSU CHEMICAL CO (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5298220-A | Forming a coating of a solution containing anioic and cationic dyes and water insoluble organonitrogen compound, drying | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-03-29 | — | — | US | disclosed |
| US-5196164-A | During addition polymerization, wall coating of anionic dye and cationic dye and organonitrogen compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1993-03-23 | — | — | US | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570676-B2 | Multifunctionalized silicon nanoparticles, process for their preparation and uses thereof in electrochemiluminescence based detection methods | SELP, SELPLG, SELE | NUDT1 3863/4885ADORA2A 4714/4885MEN1 276/4885 |
| US-12372474-B2 | Branched-chain amines in electrochemiluminescence detection | BCAT2, BCAT1, MAOB | NUDT1 567/4885ADORA2A 619/4885MEN1 2210/4885 |
| US-20050187278-A1 | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors | PDE2A, PDE3A, PDE3B | NUDT1 415/4885ADORA2A 109/4885MEN1 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.